Allahabad HC: Employees of Constituent Institutions are not Entitled to Central University Benefits  ||  Calcutta High Court: Juvenile Accused Eligible to Apply for Anticipatory Bail under Section 438 CrPC  ||  J&K & L HC: Departmental Proceedings Not Halted by Pending Criminal Case Without Showing Prejudice  ||  Cal HC: CESTAT Appeals Abate After Resolution Plan Success; CENVAT Reversal Requires No Pre-Deposit  ||  Bom HC: SEBI Settlement Doesn’t Protect Accused from Criminal Liability in Serious Economic Offences  ||  SC Directs States to Notify Eco-Sensitive Zones Around Tiger Reserves and Regulate Tiger Safaris  ||  SC: Its 2024 Order Letting Union Review Benami Act Cases Based on 'Ganpati Dealcom' was Incorrect  ||  SC: Rejection of Income Tax Settlement Application Doesn’t Bar Assessee from Contesting Assessment  ||  SC Informed Accessibility Facilities for Visually Impaired Candidates in AIBE and CLAT Expected Soon  ||  Supreme Court: Pendency of Writ Proceedings Does Not Bar Availing Alternative Statutory Remedies    

Central Government permitted M/s. Cipla Limited to import morphine, codeine, the baine and their salts after following the procedure specified in NDPS Rules- (Ministry of Finance ) (27 Aug 2020)

MANU/REVU/0064/2020

Law of Medicine

1. In exercise of the powers conferred by the proviso to rule 54 of the Narcotic Drugs and Psychotropic Substances Rules, 1985, the Central Government hereby notifies that M/s. Cipla Limited, Cipla House, Peninsula Business Park, Ganpatrao Kadma Marg, Lower Parel, Mumbai-400013, is permitted to import morphine, codeine, thebaine and their salts for use in manufacture of products to be exported, after following the procedure specified in Rule 55 of the said rules and subject to such conditions as may be specified in the import certificate issued in Form No. 4A annexed to the aforesaid rules.

2. This notification shall remain in force from the date of its publication in the Official Gazette till the 31st day of December, 2022.

Tags : CIPLA LIMITED   PERMISSION   IMPORT  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved